Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus

Rheumatology International

Volumn 29, Issue 7, 2009, Pages 735-742

  Tso, Tim K ^a   Huang, Wen Nan ^b  

^a NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Brachial ankle pulse wave velocity; Cardiovascular risk; Homocysteine; Insulin; Systemic lupus erythematosus

Indexed keywords

GLUCOSE; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; FIBRINOLYSIS; HEART RATE; HOMOCYSTEINE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LIPIDS; LIPOPROTEINS, LDL; LUPUS ERYTHEMATOSUS, SYSTEMIC; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRIGLYCERIDES; UP-REGULATION;

EID: 67349277792     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0781-7     Document Type: Article

References (39)

1. DE Moller JS Flier 1991 Insulin resistance: mechanisms, syndromes, and implications N Engl J Med 325 938 948
2. JS Flier CR Kahn J Roth 1979 Receptors, antireceptor antibodies and mechanisms of insulin resistance N Engl J Med 300 413 419
3. A Gehi A Webb M Nolte J Davis 2003 Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil Arthritis Rheum 48 1067 1070 10.1002/art.10879
4. DP D'Cruz MA Khamashta GR Hughes 2007 Systemic lupus erythematosus Lancet 369 587 596 10.1016/S0140-6736(07)60279-7
5. M Abu-Shakra MB Urowitz DD Gladman J Gough 1995 Mortality studies in systemic lupus erythematosus: results from a single center. I. Causes of death J Rheumatol 22 1259 1264
6. MM Ward 1999 Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus Arthritis Rheum 42 338 346 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U
7. JM Esdaile M Abrahamowicz T Grodzicky Y Li C Panaritis R du Berger R Cote SA Grover PR Fortin AE Clarke JL Senecal 2001 Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus Arthritis Rheum 44 2331 2337 10.1002/1529-0131(200110)44: 10<2331::AID-ART395>3.0.CO;2-I
8. IN Bruce 2005 "Not only but also": factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus Rheumatology 44 1492 1502 10.1093/rheumatology/kei142
9. E Svenungsson K Jensen-Urstad M Heimburger A Silveira A Hamsten U de Faire JL Witztum J Frostegard 2001 Risk factors for cardiovascular disease in systemic lupus erythematosus Circulation 104 1887 1893 10.1161/hc4101.097518
10. TS Hsu LA Hsu CJ Chang CF Sun YL Ko CT Kuo CW Chiang YS Lee 2001 Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study Thromb Res 102 387 395 10.1016/S0049-3848(01)00262-6
11. S Meaume A Benetos OF Henry A Rudnichi ME Safar 2001 Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age Arterioscler Thromb Vasc Biol 21 2046 2050 10.1161/hq1201.100226
12. J Brodszki C Bengtsson T Lanne O Nived G Sturfelt K Marsal 2004 Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus Lupus 13 917 923 10.1191/0961203304lu2033oa
13. WH Frishman 1998 Biologic markers as predictors of cardiovascular disease Am J Med 104 18S 27S 10.1016/S0002-9343(98)00184-3
14. M Lidar A Braf N Givol P Langevitz R Pauzner A Many A Livneh 2001 Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus Lupus 10 81 86 10.1191/096120301669081314
15. C Posadas-Romero M Torres-Tamayo J Zamora-Gonzalez BE Aguilar-Herrera R Posadas-Sanchez G Cardoso-Saldana G Ladron de Guevara E Solis-Vallejo M El Hafidi 2004 High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus Arthritis Rheum 50 160 165 10.1002/art.11472
16. TK Tso HY Huang CK Chang YJ Liao WN Huang 2004 Clinical evaluation of insulin resistance and β-cell function by the homeostasis model assessment in patients with systemic lupus erythematosus Clin Rheumatol 23 416 420 10.1007/s10067-004-0908-5
17. M El Magadmi Y Ahmad W Turkie AP Yates N Sheikh RM Bernstein PN Durrington I Laing IN Bruce 2006 Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus J Rheumatol 33 50 56
18. EM Tan AS Cohen JF Fries AT Masi DJ McShane NF Rothfield JG Schaller N Talal RJ Winchester 1982 The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1271 1277 10.1002/art.1780251101
19. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RL Turner 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 10.1007/BF00280883
20. WT Friedewald RI Levy DS Fredrickson 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 499 502
21. PI Oteiza KL Olin CG Fraga CL Keen 1995 Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes J Nutr 125 823 829
22. TK Tso WN Huang HY Huang CK Chang 2005 Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus Lupus 14 878 883 10.1191/0961203305lu2234oa
23. C Bombardier DD Gladman MB Urowitz D Caron CH Chang 1992 Derivation of the SLEDAI: a disease activity index for lupus patients Arthritis Rheum 35 630 640 10.1002/art.1780350606
24. DM Chang JL Lan HY Lin SF Luo 2002 Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus Arthritis Rheum 46 2924 2927 10.1002/art.10615
25. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection 2002 Evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) Final Rep Circ 106 3143 3421
26. KE Sada Y Yamasaki M Maruyama H Sugiyama M Yamamura Y Maeshima H Makino 2006 Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus J Rheumatol 33 1545 1552
27. SR Lentz WG Haynes 2004 Homocysteine: is it a clinically important cardiovascular risk factor? Cleve Clin J Med 71 729 734
28. A Yamashina H Tomiyama T Arai K Hirose Y Koji Y Hirayama Y Yamamoto S Hori 2003 Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk Hypertens Res 26 615 622 10.1291/hypres.26.615
29. AS Wierzbicki 2000 Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus Lupus 9 194 201 10.1191/096120300678828235
30. F Formiga JF Meco X Pinto J Jacob I Moga R Pujol 2001 Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients Lupus 10 359 363 10.1191/096120301669070811
31. J Frostegard E Svenungsson R Wu I Gunnarsson IE Lundberg L Klareskog S Horkko JL Witztum 2005 Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations Arthritis Rheum 52 192 200 10.1002/art.20780
32. TMK Refai IH Al-Salem D Nkansa-Dwamena MH Al-Salem 2002 Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients Clin Rheumatol 21 457 461 10.1007/s100670200115
33. M Petri R Roubenoff GE Dallal MR Nadeau J Selhub IH Rosenberg 1996 Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus Lancet 348 1120 1124 10.1016/S0140-6736(96)03032-2
34. WHH Sheu WJ Lee YT Chen 2000 Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects Am J Hypertens 13 14 20 10.1016/S0895-7061(99)00138-7
35. VA Fonseca S Mudaliar B Schmidt LM Fink PA Kern RR Henry 1998 Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects Metabolism 47 686 689 10.1016/S0026-0495(98)90031-2
36. JP Bastard L Pieroni B Hainque 2000 Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance Diabetes Metab Res Rev 16 192 201 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114<3.0.CO;2-G
37. JB Meigs MA Mittleman DM Nathan GH Tofler DE Singer PM Murphy-Sheehy I Lipinska RB D'Agostino PW Wilson 2000 Hyperinsulinemia, hyperglycemia and impaired hemostatis: the Framingham offspring study JAMA 283 221 228 10.1001/jama.283.2.221
38. A Festa R D'Agostino Jr L Mykkanen RP Tracy DJ Zaccaro CN Hales SM Haffner 1999 Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The insulin resistance atherosclerosis study (IRAS) Arterioscler Thromb Vasc Biol 19 562 568
39. F Selzer K Sutton-Tyrrell S Fitzgerald R Tracy L Kuller S Manzi 2001 Vascular stiffness in women with systemic lupus erythematosus Hypertension 37 1075 1082